TY - JOUR
T1 - Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the β3-adrenoreceptor
AU - Moens, An L.
AU - Leyton-Mange, Jordan S.
AU - Niu, Xiaolin
AU - Yang, Ronghua
AU - Cingolani, Oscar
AU - Arkenbout, Elisabeth K.
AU - Champion, Hunter C.
AU - Bedja, Djahida
AU - Gabrielson, Kathleen L.
AU - Chen, Juan
AU - Xia, Yong
AU - Hale, Ashley B.
AU - Channon, Keith M.
AU - Halushka, Marc K.
AU - Barker, Norman
AU - Wuyts, Floris L.
AU - Kaminski, Pawel M.
AU - Wolin, Michael S.
AU - Kass, David A.
AU - Barouch, Lili A.
PY - 2009/11
Y1 - 2009/11
N2 - Stimulation of the β-adrenergic system is important in the pathological response to sustained cardiac stress, forming the rationale for the use of β-blockers in heart failure. The β3-adrenoreceptor (AR) is thought to couple to the inhibitory G-protein, Gi, with downstream signaling through nitric oxide, although its role in the heart remains controversial. In this study, we tested whether lack of β3-AR influences the myocardial response to pressure-overload. Baseline echocardiography in mice lacking β3-AR (β3-/-) compared to wild type (WT) showed mild LV hypertrophy at 8 weeks that worsened as they aged. β3-/- mice had much greater mortality after transverse aortic constriction (TAC) than WT controls. By 3 weeks of TAC, systolic function was worse. After 9 weeks of TAC, β3-/- mice also had greater LV dilation, myocyte hypertrophy and enhanced fibrosis. NOS activity declined in β3-/-TAC hearts after 9 weeks, and total and NOS-dependent superoxide rose, indicating heightened oxidative stress and NOS uncoupling. The level of eNOS phosphorylation in β3-/-TAC hearts was diminished, and nNOS and iNOS expression levels were increased. GTP cyclohydrolase-1 expression was reduced, although total BH4 levels were not depleted. 3 weeks of BH4 treatment rescued β3-/- mice from worsened remodeling after TAC, and lowered NOS-dependent superoxide. Thus, lack of β3-AR signaling exacerbates cardiac pressure-overload induced remodeling and enhances NOS uncoupling and consequent oxidant stress, all of which can be rescued with exogenous BH4. These data suggest a cardioprotective role for the β3-AR in modulating oxidative stress and adverse remodeling in the failing heart.
AB - Stimulation of the β-adrenergic system is important in the pathological response to sustained cardiac stress, forming the rationale for the use of β-blockers in heart failure. The β3-adrenoreceptor (AR) is thought to couple to the inhibitory G-protein, Gi, with downstream signaling through nitric oxide, although its role in the heart remains controversial. In this study, we tested whether lack of β3-AR influences the myocardial response to pressure-overload. Baseline echocardiography in mice lacking β3-AR (β3-/-) compared to wild type (WT) showed mild LV hypertrophy at 8 weeks that worsened as they aged. β3-/- mice had much greater mortality after transverse aortic constriction (TAC) than WT controls. By 3 weeks of TAC, systolic function was worse. After 9 weeks of TAC, β3-/- mice also had greater LV dilation, myocyte hypertrophy and enhanced fibrosis. NOS activity declined in β3-/-TAC hearts after 9 weeks, and total and NOS-dependent superoxide rose, indicating heightened oxidative stress and NOS uncoupling. The level of eNOS phosphorylation in β3-/-TAC hearts was diminished, and nNOS and iNOS expression levels were increased. GTP cyclohydrolase-1 expression was reduced, although total BH4 levels were not depleted. 3 weeks of BH4 treatment rescued β3-/- mice from worsened remodeling after TAC, and lowered NOS-dependent superoxide. Thus, lack of β3-AR signaling exacerbates cardiac pressure-overload induced remodeling and enhances NOS uncoupling and consequent oxidant stress, all of which can be rescued with exogenous BH4. These data suggest a cardioprotective role for the β3-AR in modulating oxidative stress and adverse remodeling in the failing heart.
UR - http://www.scopus.com/inward/record.url?scp=70349755909&partnerID=8YFLogxK
U2 - 10.1016/j.yjmcc.2009.06.005
DO - 10.1016/j.yjmcc.2009.06.005
M3 - Article
C2 - 19766235
AN - SCOPUS:70349755909
VL - 47
SP - 576
EP - 585
JO - Journal of Molecular and Cellular Cardiology
JF - Journal of Molecular and Cellular Cardiology
SN - 0022-2828
IS - 5
ER -